MenQuadfi, solution injectable

7680682210015 CH-68221 Injektionslösung
MenQuadfi, solution injectable
MenQuadfi, solution injectable
MenQuadfi, solution injectable
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
23/05/2025
Summary of Product Characteristics
Français
23/05/2025
Summary of Product Characteristics
Italien
23/05/2025

Detailed composition

Substance Quantity Type Category
(N/A)
10.0 UG Substance Wirkstoff (Principe actif)
(N/A)
10.0 UG Substance Wirkstoff (Principe actif)
(N/A)
10.0 UG Substance Wirkstoff (Principe actif)
(N/A)
10.0 UG Substance WIIS
(N/A)
55.0 UG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
1.67 MG Substance HBESI

Reimbursement information

Public price
CHF 61.15
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/06/2023

Authorization holder

Sanofi-Aventis (Suisse) SA

1214 Vernier

Authorization information

Swissmedic authorization number
68221
Drug name
MenQuadfi, solution injectable
Galenic form
LSPA
ATC Code
J07AH08
Authorization status
Z
Dispensing category
B
First authorization
05/10/2022
Authorization expiration date
04/10/2027
IT Number
08.08.
Domain
Human medicine

Package details

Description (FR)
MENQUADFI sol inj flac 0.5 ml
Description (DE)
MENQUADFI Inj Lös Durchstf 0.5 ml
Market launch
05/10/2022
Narcotic (BTM)
No

Other package sizes (1)

None
None None
GTIN: None
Not in V1